Modification of risk for cancer as a coincidental finding in DNA array investigation.

about

So rare we need to hunt for them: reframing the ethical debate on incidental findings.

P2860

Q35902802-806A1755-4977-4A30-B0CB-6874C51C81BF

P2860

Modification of risk for cancer as a coincidental finding in DNA array investigation.

Item

http://www.wikidata.org/entity/Q48608170

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Modification of risk for cancer as a coincidental finding in DNA array investigation.

@en

Modification of risk for cancer as a coincidental finding in DNA array investigation.

@nl

type

Item

label

Modification of risk for cancer as a coincidental finding in DNA array investigation.

@en

Modification of risk for cancer as a coincidental finding in DNA array investigation.

@nl

prefLabel

Modification of risk for cancer as a coincidental finding in DNA array investigation.

@en

Modification of risk for cancer as a coincidental finding in DNA array investigation.

@nl

P1476

Modification of risk for cancer as a coincidental finding in DNA array investigation.

@en

P2093

A Frühmesser

http://www.w3.org/2001/XMLSchema#string

B Krabichler

http://www.w3.org/2001/XMLSchema#string

C Fauth

http://www.w3.org/2001/XMLSchema#string

D Kotzot

http://www.w3.org/2001/XMLSchema#string

I Laimer

http://www.w3.org/2001/XMLSchema#string

K Gautsch

http://www.w3.org/2001/XMLSchema#string

K Rostasy

http://www.w3.org/2001/XMLSchema#string

K Wimmer

http://www.w3.org/2001/XMLSchema#string

S Moshir

http://www.w3.org/2001/XMLSchema#string

P2860

Neurofibromatosis type 2 (NF2): a clinical and molecular review

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

Constitutional haploinsufficiency of tumor suppressor genes in mentally retarded patients with microdeletions in 17p13.1.

Clinical utility of array comparative genomic hybridization: uncovering tumor susceptibility in individuals with developmental delay

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.

Predictive diagnosis of the cancer prone Li-Fraumeni syndrome by accident: new challenges through whole genome array testing.

Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls.

Cancer risk in children with birth defects and in their families: a population based cohort study of 5.2 million children from Norway and Sweden.

Further genotype--phenotype correlations in neurofibromatosis 2.

Unexpected findings in cancer predisposition genes detected by array comparative genomic hybridisation: what are the issues?

P304

284-287

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1399-0004.2012.01881.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22428932

http://www.w3.org/2001/XMLSchema#string

Modification of risk for cancer as a coincidental finding in DNA array investigation.

about

P2860

P2860

Modification of risk for cancer as a coincidental finding in DNA array investigation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698